| Size & multiples | |||
| Market Cap | $2.15B | Enterprise Value | $3.26B |
| P/E (TTM) | 9.42× | PEG (trailing) | — |
| P/S | 0.85× | P/FCF | 17.52× |
| EV/EBITDA | 11.45× | EV/EBIT | 11.90× |
| EV/Sales | 1.29× | EV/FCF | 26.54× |
| FCF Yield | 5.71% | Buyback Yield | — |
| Owner Earnings (TTM) | $261.5M | Owner Earnings Yield | 12.14% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 2.12 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 14.62% |
| After-tax Cost of Debt | 10.25% | Synthetic credit rating | B |
| Cost of Debt · embedded (pre-tax) | 10.25% | Cost of Debt · marginal (synthetic) | 7.21% |
| WACC | 12.98% | ROIC | — |
| EVA Spread (ROIC−WACC) | — | EVA | — |
FCF sits 53% below owner earnings — spending above maintenance (growth capex) or absorbing working capital, so FCF understates the steady-state cash the business throws off.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $1.05 · revenue TTM $2.52B · FCF TTM $122.9M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Cheap vs Health Care on P/E, EV/EBITDA
P/E 18th · EV/EBITDA 36th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 9.4x | 24.4x | 12.9x–38.8x | 18 ↓cheap |
| EV/EBITDA | 12.2x | 15.2x | 9.9x–24.7x | 36 ↓cheap |
| FCF Yield | 5.1% | -7.9% | -35.6%–1.4% | 87 ↑strong |
| Net Margin | 9.2% | -21.2% | -325.3%–7.2% | 79 ↑strong |
| Operating Margin | 10.5% | -34.5% | -552.0%–8.0% | 79 ↑strong |
